KALA BIO, Inc. Deal History & Licensing Activity
KALA BIO, Inc. is a life sciences. Over the past three years, KALA BIO, Inc. has been involved in 1 licensing and acquisition transaction, with a primary focus on Other (2 deals).
Deals (12mo)
1
Active Trials
0
Top Modality
Other
Focus Area
Ophthalmology
KALA BIO, Inc. Recent Deal Activity
Licensing, acquisition, and partnership transactions involving KALA BIO, Inc. in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| Researgency | 2624465 Ontario Inc., operating as Younet AI | Other | Unknown | license | Mar 4, 2026 |
KALA BIO, Inc. Pipeline Focus
Therapeutic areas and modalities where KALA BIO, Inc. is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
See How Your Asset Matches KALA BIO, Inc.'s Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Ophthalmology assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Ophthalmology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for ophthalmology
Other Benchmarks
Upfront, milestone, and royalty benchmarks for other deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About KALA BIO, Inc. Licensing & Deal Activity
KALA BIO, Inc. is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, KALA BIO, Inc. ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for KALA BIO, Inc. include Ophthalmology (2 deals and trials). In terms of modality, KALA BIO, Inc. has shown particular interest in other.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for KALA BIO, Inc. and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against KALA BIO, Inc.'s historical deal terms, or explore all company profiles to find the best partner match for your pipeline.